Pozanicline clinical trials
Also written ABT-089.
- studies test it
- 11
- open now
- 0
- in phase 3
- 0
- first study started
- 2003
How each study uses pozanicline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
11 studies that test it; most in 2007 (4)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 11
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 1
AbbVie (prior sponsor, Abbott) (5) · Abbott (5) · University of Pennsylvania (1)
Studies
Open first, then newest update. How each study uses pozanicline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 11
- Effects of ABT-089 on Smoking Abstinence Symptoms and RewardTerminatedPhase 2University of PennsylvaniaNCT01756053Written as ABT-089How we know
- A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2AbbVie (prior sponsor, Abbott)NCT00528697Written as ABT-089How we know
- Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2AbbVie (prior sponsor, Abbott)NCT00686933Written as ABT-089How we know
- A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)CompletedPhase 2AbbVie (prior sponsor, Abbott)NCT00443391Written as ABT-089How we know
- Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2AbbVie (prior sponsor, Abbott)NCT00640419Written as ABT-089How we know
- Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2AbbVie (prior sponsor, Abbott)NCT00640185Written as ABT-089How we know
- A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2AbbottNCT00391729Written as ABT-089How we know
- A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 StudyTerminatedPhase 2AbbottNCT00809510Written as ABT-089How we know
- Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's DiseaseTerminatedPhase 2AbbottNCT00555204Written as ABT-089How we know
- A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)TerminatedPhase 2AbbottNCT00554385Written as ABT-089How we know
- A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's DiseaseTerminatedPhase 2AbbottNCT00069849Written as ABT-089How we know
Codes
What other systems call pozanicline · ClinicalTrials.gg INT004017
- MeSH (NLM) C108326pozaniclineOne source NLM
- UNII (FDA) CL2002R563POZANICLINEConfirmed FDA, NLM, Wikidata
- Wikidata Q14664566pozaniclineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81045PozaniclineOne source FDA
- DrugBank DB05458One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C108326 | pozanicline | One source NLM |
| UNII (FDA) | CL2002R563 | POZANICLINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q14664566 | pozanicline | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81045 | Pozanicline | One source FDA |
| DrugBank | DB05458 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.